Literature DB >> 31201277

A New Suite of Allelic-Exchange Vectors for the Scarless Modification of Proteobacterial Genomes.

Jacob E Lazarus1,2, Alyson R Warr2,3, Carole J Kuehl2,3, Rachel T Giorgio2,3, Brigid M Davis2,3, Matthew K Waldor4,3,5.   

Abstract

Despite the advent of new techniques for genetic engineering of bacteria, allelic exchange through homologous recombination remains an important tool for genetic analysis. Currently, sacB-based vector systems are often used for allelic exchange, but counterselection escape, which prevents isolation of cells with the desired mutation, occasionally limits their utility. To circumvent this, we engineered a series of "pTOX" allelic-exchange vectors. Each plasmid encodes one of a set of inducible toxins, chosen for their potential utility in a wide range of medically important proteobacteria. A codon-optimized rhaS transcriptional activator with a strong synthetic ribosome-binding site enables tight toxin induction even in organisms lacking an endogenous rhamnose regulon. Expression of the gene encoding blue AmilCP or magenta TsPurple nonfluorescent chromoprotein facilitates monitoring of successful single- and double-crossover events using these vectors. The versatility of these vectors was demonstrated by deleting genes in Serratia marcescens, Escherichia coli O157:H7, Enterobacter cloacae, and Shigella flexneri Finally, pTOX was used to characterize the impact of disruption of all combinations of the 3 paralogous S. marcescens peptidoglycan amidohydrolases on chromosomal ampC β-lactamase activity and the corresponding β-lactam antibiotic resistance. Mutation of multiple amidohydrolases was necessary for high-level ampC derepression and β-lactam resistance. These data suggest why β-lactam resistance may emerge during treatment less frequently in S. marcescens than in other AmpC-producing pathogens, like E. cloacae Collectively, our findings suggest that the pTOX vectors should be broadly useful for genetic engineering of Gram-negative bacteria.IMPORTANCE Targeted modification of bacterial genomes is critical for genetic analysis of microorganisms. Allelic exchange is a technique that relies on homologous recombination to replace native loci with engineered sequences. However, current allelic-exchange vectors often enable only weak selection for successful homologous recombination. We developed a suite of new allelic-exchange vectors, pTOX, which were validated in several medically important proteobacteria. They encode visible nonfluorescent chromoproteins that enable easy identification of colonies bearing integrated vectors and permit stringent selection for the second step of homologous recombination. We demonstrate the utility of these vectors by using them to investigate the effect of inactivation of Serratia marcescens peptidoglycan amidohydrolases on β-lactam antibiotic resistance.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  AmilCP gene; Serratia marcescens; allelic exchange; ampC; ampD; antibiotic resistance; beta-lactamase; sacB; toxin-antitoxin; type VI toxin

Mesh:

Substances:

Year:  2019        PMID: 31201277      PMCID: PMC6677854          DOI: 10.1128/AEM.00990-19

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  44 in total

1.  Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria.

Authors:  Nadège Philippe; Jean-Pierre Alcaraz; Evelyne Coursange; Johannes Geiselmann; Dominique Schneider
Journal:  Plasmid       Date:  2004-05       Impact factor: 3.466

2.  Gentamicin and other cassettes for chromosomal gene replacement in Escherichia coli.

Authors:  Anthony R Poteete; Charles Rosadini; Christine St Pierre
Journal:  Biotechniques       Date:  2006-09       Impact factor: 1.993

3.  Genetic system for reversible integration of DNA constructs and lacZ gene fusions into the Escherichia coli chromosome.

Authors:  R Platt; C Drescher; S K Park; G J Phillips
Journal:  Plasmid       Date:  2000-01       Impact factor: 3.466

4.  Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system.

Authors:  Matthew J Giacalone; Angela M Gentile; Brian T Lovitt; Neil L Berkley; Carl W Gunderson; Mark W Surber
Journal:  Biotechniques       Date:  2006-03       Impact factor: 1.993

5.  Transcriptional downregulator hexS controlling prodigiosin and serrawettin W1 biosynthesis in Serratia marcescens.

Authors:  Taichiro Tanikawa; Yoji Nakagawa; Tohey Matsuyama
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

6.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

Authors:  Irith Wiegand; Kai Hilpert; Robert E W Hancock
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

7.  Mutations that impair swarming motility in Serratia marcescens 274 include but are not limited to those affecting chemotaxis or flagellar function.

Authors:  J O'Rear; L Alberti; R M Harshey
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

8.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

Authors:  J W Chow; M J Fine; D M Shlaes; J P Quinn; D C Hooper; M P Johnson; R Ramphal; M M Wagener; D K Miyashiro; V L Yu
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

9.  Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa.

Authors:  Bartolomé Moya; Carlos Juan; Sebastián Albertí; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

10.  Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.

Authors:  Sang-Ho Choi; Jung Eun Lee; Su Jin Park; Seong-Ho Choi; Sang-Oh Lee; Jin-Yong Jeong; Mi-Na Kim; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

View more
  7 in total

1.  Genetic analysis of the role of the conserved inner membrane protein CvpA in EHEC resistance to deoxycholate.

Authors:  Alyson R Warr; Rachel T Giorgio; Matthew K Waldor
Journal:  J Bacteriol       Date:  2020-12-23       Impact factor: 3.490

2.  A Genome-Scale Antibiotic Screen in Serratia marcescens Identifies YdgH as a Conserved Modifier of Cephalosporin and Detergent Susceptibility.

Authors:  Jacob E Lazarus; Alyson R Warr; Kathleen A Westervelt; David C Hooper; Matthew K Waldor
Journal:  Antimicrob Agents Chemother       Date:  2021-09-07       Impact factor: 5.191

3.  Genetic Manipulation of Wild Human Gut Bacteroides.

Authors:  Natasha A Bencivenga-Barry; Bentley Lim; Carmen M Herrera; M Stephen Trent; Andrew L Goodman
Journal:  J Bacteriol       Date:  2020-01-15       Impact factor: 3.490

4.  Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota.

Authors:  Leonor García-Bayona; Laurie E Comstock
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

5.  Lytic transglycosylases mitigate periplasmic crowding by degrading soluble cell wall turnover products.

Authors:  Anna Isabell Weaver; Laura Alvarez; Kelly M Rosch; Asraa Ahmed; Garrett Sean Wang; Michael S van Nieuwenhze; Felipe Cava; Tobias Dörr
Journal:  Elife       Date:  2022-01-24       Impact factor: 8.140

6.  High-level carbapenem tolerance requires antibiotic-induced outer membrane modifications.

Authors:  Andrew N Murtha; Misha I Kazi; Richard D Schargel; Trevor Cross; Conrad Fihn; Vincent Cattoir; Erin E Carlson; Joseph M Boll; Tobias Dörr
Journal:  PLoS Pathog       Date:  2022-02-07       Impact factor: 6.823

7.  Identification of distinct capsule types associated with Serratia marcescens infection isolates.

Authors:  Mark T Anderson; Stephanie D Himpsl; Lindsay A Mitchell; Leandra G Kingsley; Elizabeth P Snider; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2022-03-30       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.